MTA1 and prostate carcinoma: We demonstrated that Gnetin C inhibited MTA1-mediated cell viability, clonogenic survival, migration and induced MTA1-mediated apoptosis more potently than Res and Pter in prostate cancer cells specifically acting through MTA1/ETS2 pathway [28,39].